These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 23488616)

  • 1. Design, synthesis, and structure-activity relationship studies of fluorescent inhibitors of cycloxygenase-2 as targeted optical imaging agents.
    Uddin MJ; Crews BC; Ghebreselasie K; Marnett LJ
    Bioconjug Chem; 2013 Apr; 24(4):712-23. PubMed ID: 23488616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. One-Pot Synthesis of Coumarin-Indomethacin Hybrids as COX-2 Targeting Probes for Cancer Imaging.
    Wet-Osot S; Pewklang T; Chansaenpak K; Chudapongse N; Lai RY; Kamkaew A
    ChemMedChem; 2021 May; 16(10):1660-1666. PubMed ID: 33586347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ester and amide derivatives of the nonsteroidal antiinflammatory drug, indomethacin, as selective cyclooxygenase-2 inhibitors.
    Kalgutkar AS; Marnett AB; Crews BC; Remmel RP; Marnett LJ
    J Med Chem; 2000 Jul; 43(15):2860-70. PubMed ID: 10956194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective visualization of cyclooxygenase-2 in inflammation and cancer by targeted fluorescent imaging agents.
    Uddin MJ; Crews BC; Blobaum AL; Kingsley PJ; Gorden DL; McIntyre JO; Matrisian LM; Subbaramaiah K; Dannenberg AJ; Piston DW; Marnett LJ
    Cancer Res; 2010 May; 70(9):3618-27. PubMed ID: 20430759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Celecoxib Conjugated Fluorescent Probe for Identification and Discrimination of Cyclooxygenase-2 Enzyme in Cancer Cells.
    Gurram B; Zhang S; Li M; Li H; Xie Y; Cui H; Du J; Fan J; Wang J; Peng X
    Anal Chem; 2018 Apr; 90(8):5187-5193. PubMed ID: 29587478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and cycloxygenase inhibitory properties of new naphthalene-methylsulfonamido, naphthalene-methylsulfonyl and tetrahydronaphthalen-methylsulfonamido compounds.
    Nencetti S; Ciccone L; Rossello A; Nuti E; Milanese C; Orlandini E
    J Enzyme Inhib Med Chem; 2015 Jun; 30(3):406-12. PubMed ID: 25089708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indolyl esters and amides related to indomethacin are selective COX-2 inhibitors.
    Kalgutkar AS; Crews BC; Saleh S; Prudhomme D; Marnett LJ
    Bioorg Med Chem; 2005 Dec; 13(24):6810-22. PubMed ID: 16169736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting COX-1 by mofezolac-based fluorescent probes for ovarian cancer detection.
    Scilimati A; Ferorelli S; Iaselli MC; Miciaccia M; Pati ML; Fortuna CG; Aleem AM; Marnett LJ; Perrone MG
    Eur J Med Chem; 2019 Oct; 179():16-25. PubMed ID: 31229884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pyrimidine-based fluorescent COX-2 inhibitors: synthesis and biological evaluation.
    Tietz O; Kaur J; Bhardwaj A; Wuest FR
    Org Biomol Chem; 2016 Jul; 14(30):7250-7. PubMed ID: 27383140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular imaging of cyclooxygenase-2 in canine transitional cell carcinomas in vitro and in vivo.
    Cekanova M; Uddin MJ; Bartges JW; Callens A; Legendre AM; Rathore K; Wright L; Carter A; Marnett LJ
    Cancer Prev Res (Phila); 2013 May; 6(5):466-76. PubMed ID: 23531445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluorinated COX-2 inhibitors as agents in PET imaging of inflammation and cancer.
    Uddin MJ; Crews BC; Ghebreselasie K; Huda I; Kingsley PJ; Ansari MS; Tantawy MN; Reese J; Marnett LJ
    Cancer Prev Res (Phila); 2011 Oct; 4(10):1536-45. PubMed ID: 21900596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis, biological evaluation and molecular modeling of dihydropyrazole sulfonamide derivatives as potential COX-1/COX-2 inhibitors.
    Chen Z; Wang ZC; Yan XQ; Wang PF; Lu XY; Chen LW; Zhu HL; Zhang HW
    Bioorg Med Chem Lett; 2015 May; 25(9):1947-51. PubMed ID: 25866240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Covalent modification of cyclooxygenase-2 (COX-2) by 2-acetoxyphenyl alkyl sulfides, a new class of selective COX-2 inactivators.
    Kalgutkar AS; Kozak KR; Crews BC; Hochgesang GP; Marnett LJ
    J Med Chem; 1998 Nov; 41(24):4800-18. PubMed ID: 9822550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis and analgesic/anti-inflammatory evaluation of novel diarylthiazole and diarylimidazole derivatives towards selective COX-1 inhibitors with better gastric profile.
    Abdelazeem AH; El-Saadi MT; Safi El-Din AG; Omar HA; El-Moghazy SM
    Bioorg Med Chem; 2017 Jan; 25(2):665-676. PubMed ID: 27916468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and synthesis of new 1,3-benzthiazinan-4-one derivatives as selective cyclooxygenase (COX-2) inhibitors.
    Zarghi A; Zebardast T; Daraie B; Hedayati M
    Bioorg Med Chem; 2009 Aug; 17(15):5369-73. PubMed ID: 19596198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rational design, synthesis and evaluation of chromone-indole and chromone-pyrazole based conjugates: identification of a lead for anti-inflammatory drug.
    Shaveta ; Singh A; Kaur M; Sharma S; Bhatti R; Singh P
    Eur J Med Chem; 2014 Apr; 77():185-92. PubMed ID: 24631898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluorophore-labeled cyclooxygenase-2 inhibitors for the imaging of cyclooxygenase-2 overexpression in cancer: synthesis and biological studies.
    Bhardwaj A; Kaur J; Wuest F; Knaus EE
    ChemMedChem; 2014 Jan; 9(1):109-16, 240. PubMed ID: 24376205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and biological evaluation as well as in silico studies of arylpiperazine-1,2-benzothiazine derivatives as novel anti-inflammatory agents.
    Szczęśniak-Sięga BM; Wiatrak B; Czyżnikowska Ż; Janczak J; Wiglusz RJ; Maniewska J
    Bioorg Chem; 2021 Jan; 106():104476. PubMed ID: 33250206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis and molecular docking of benzophenone conjugated with oxadiazole sulphur bridge pyrazole pharmacophores as anti inflammatory and analgesic agents.
    Zabiulla ; Gulnaz AR; Mohammed YHE; Khanum SA
    Bioorg Chem; 2019 Nov; 92():103220. PubMed ID: 31493708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New indomethacin analogs as selective COX-2 inhibitors: Synthesis, COX-1/2 inhibitory activity, anti-inflammatory, ulcerogenicity, histopathological, and docking studies.
    Abdellatif KRA; Abdelall EKA; Elshemy HAH; El-Nahass ES; Abdel-Fattah MM; Abdelgawad YYM
    Arch Pharm (Weinheim); 2021 Apr; 354(4):e2000328. PubMed ID: 33314237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.